Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Brindisi – page 3

43 clinical trials in Brindisi, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Brindisi at a glance
43
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

43 trials in Brindisi

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universita Degli Studi Di Padova
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Thalassaemia

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:Fondazione GONO G.I.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen - Cilag International
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ETOP IBCSG Partners Foundation
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Brindisi

What the registry says about research in the country

01 Hematologic Oncology

Innovative clinical trials focusing on Acute Myeloid Leukemia and Follicular Lymphoma, investigating new therapeutic approaches including targeted treatments and immunotherapy combinations.

  • Gemtuzumab Ozogamicin therapy evaluation
  • Shortened chemotherapy with immunotherapy
  • Mocravimod in transplant patients

Research aims to improve treatment outcomes and patient survival rates through personalized therapeutic strategies.

02 Breast Cancer Research

Comprehensive studies on various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease variants.

  • Hormone therapy optimization
  • Novel drug combinations
  • Treatment sequencing strategies

Investigations aim to enhance treatment efficacy through targeted therapies and precision medicine approaches.

03 Gynecologic Oncology

Advanced research in ovarian cancer and related conditions, with particular emphasis on maintenance therapies and biomarker-driven treatment approaches.

  • BRCA-related studies
  • Maintenance therapy evaluation
  • Novel combination treatments

Studies focus on improving progression-free survival and identifying effective treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.